|
||
Date of Report (Date of earliest event reported)
|
||
|
||
(Exact name of registrant as specified in its charter)
|
|
|
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
|
||
(Address of principal executive offices and zip code)
|
||
(
|
||
(Registrant’s telephone number, including area code)
|
||
N/A
|
||
(Former name or former address, if changed since last report)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 7.01 |
Regulation FD Disclosure.
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Letter to Shareholders, excerpted from the Nu Skin Enterprises, Inc. 2020 Annual Report to Shareholders.
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
NU SKIN ENTERPRISES, INC.
|
||
(Registrant)
|
||
/s/ Mark H. Lawrence
|
||
Mark H. Lawrence
|
||
Chief Financial Officer
|
||
Date: April 19, 2021
|